FIELD: medicine, transplantation, immunology. SUBSTANCE: method involves administration of leukocyte and macrophage attractant 2-3 h before transplantation. EFFECT: improved method of SUPPRESSION. 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INDUCTION OF AN ABSCOPAL ANTITUMOR EFFECT IN THE EXPERIMENTAL MODEL OF EHRLICH'S CARCINOMA | 2020 |
|
RU2736120C2 |
ANTI-CANCER TARGETED IMMUNOTHERAPY WITH APPLICATION OF IL-12 | 2015 |
|
RU2689160C2 |
DRUG POSSESSING INTERFERON-INDUCING AND IMMUNOMODULATING (IMMUNOSTIMULATING) ACTIVITY | 1987 |
|
RU2033157C1 |
MICROFLUIDIZED COMPOSITION FOR INDUCTION OF SPECIFIC CYTOTOXIC T-LYMPHOCYTE IMMUNE RESPONSE AND ITS USING FOR DISEASE TREATMENT | 1995 |
|
RU2201253C2 |
COMBINATION OF RECOMBINANT MICROBACTERIUM AND BIOLOGICALLY ACTIVE AGENT AS VACCINE | 2005 |
|
RU2495677C2 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR METASTATIC BREAST CANCER TREATMENT | 2015 |
|
RU2624862C2 |
VACCINE FOR ANTITUMOR IMMUNITY STIMULATION | 2000 |
|
RU2192884C2 |
PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR TREATMENT OF METASTATIC BREAST CANCER OF CATS AND DOGS | 2015 |
|
RU2612015C2 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
Authors
Dates
1997-02-10—Published
1993-02-01—Filed